🔗 Share this article

An underground market for unlicensed slimming medications is propelled by TikTok fitness influencers and sellers on messaging platforms, based on new investigations.

Experimental Treatment Acquiring Traction Online

Retatrutide, which is still in research studies, is being promoted by social media influencers for its supposed fat-burning properties. Viewers are encouraged to contact these accounts privately for source information, while also obtaining discount codes.

Thriving Trade on Social Networks

Separately, a flourishing trade exists on messaging services, where groups with thousands of members share comparison images, administration instructions and assertions of next-day UK delivery. Sellers promote the drug there before redirecting buyers to other platforms for purchases.

Understanding The Experimental Drug

Retatrutide is an experimental injectable developed by US drugmaker Eli Lilly. The treatment targets three gut hormones – glucagon-like peptide-1, GIP and glucagon. Preliminary studies indicate it could help patients lose up to 25% of their total weight. Nicknamed the “triple G”, the substance is being hailed online as the successor to Ozempic.

Healthcare Professionals Express Concerns

However, doctors and pharmacists have cautions that the distribution of what remains an unapproved medication in the United Kingdom is worrisome and could lead to users administering substances of uncertain source.

Several experts stated the demand for the experimental drug could be linked to the rising price of approved slimming products such as Mounjaro.

Legal Position and Enforcement

Selling the unapproved drug on TikTok or Telegram is illegal in the UK, as it is an unlicensed medication that cannot be promoted or distributed for personal consumption under the Human Medicines Regulations 2012.

Some influencers try to sidestep the regulations by calling to the drug as a “research chemical” or describing it as “not for human consumption”. The substance is not a restricted substance, but advertising and supply can still breach pharmaceutical, advertising, and customer laws, risking fines, prosecution or imprisonment.

Service Response and Content Elimination

Based on the social media company, the platform has removed problematic material and banned associated keywords and search suggestions. The organization said it was dedicated to maintaining the platform secure and allocating resources in enhancing enforcement strategies.

Online Marketplace Operations

Research also discovered communities with up to 9,000 participants marketing retatrutide using the platform's integrated search feature, which operates like a online catalog. Typing “retatrutide” instantly displays groups with thousands of users, populated with photos of weight loss, glowing testimonials and detailed guides for preparing or injecting at home.

Within minutes of entering one group, a seller posted contact information, where the majority of transactions occur. The seller provided an guidebook and promised shipping within two days. When questioned whether the substance was genuine, one seller said: “You can’t be sure.” Another shared a photo of a supposed testing documentation. None inquired about weight, health issues or previous experience.

Item Details and Costs

Inside these groups, messages show black plastic packages with postal service stickers, claiming to contain new batches. One message read: “It took eight of us to load them this morning.”

Customers can select between dry substance containers, mixed at residence with sterile water, or ready-to-use pens usually sold at £160 for 20 milligrams. When asked how much time a pen should last, sellers give contradictory answers varying between a several days to “depends on your body”.

Service Moderation and Security Actions

A spokesperson for the messaging service said it actively monitored harmful material on its service including material that promoted the “misuse of controlled medications”. The company added that it eliminated “millions of pieces of harmful content each day”.

Medical Expert Warnings

“People are administering materials they cannot confirm. Although the research behind retatrutide is valid, these online versions may not contain what they claim,” stated Jason Murphy, the director of pharmacy at Chemist4U.

A medical professional of an online medical service linked the increase in interest to recent price rises for approved slimming drugs such as Mounjaro. “With costs rising, patients are turning to social media. But fake treatments are extremely risky. You cannot know what’s contained or whether the environment they were made in was sterile,” she explained.

Her staff has previously seen individuals harmed by self-injection from unconfirmed sources. “We understand the frustration, but buying from Telegram or WhatsApp is taking chances with your well-being,” said Wyllie. “These substances could be impure or improperly measured.”

Producer Statement

A spokesperson from the pharmaceutical company stated the substance was in phase 3 clinical trials and had not been evaluated or authorized by any regulatory agency anywhere in the world. “Therefore at this point no one can market [it] for human use,” they said, noting that any item “falsely representing itself as a Lilly investigational substance not yet approved … may expose users to possibly serious health risks”.